The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages
Open accessAbstract
The ATP-binding cassette transporter A1 (ABCA1) encodes a membrane protein that promotes cholesterol and phospholipid efflux from cells. Mutations in ABCA1 lead to HDL deficiency and tissue accumulation of macrophages in patients with homozygous Tangier disease. In this study, we examined whether the complete absence of ABCA1 or selected inactivation in macrophages is accompanied by an increase in atherosclerotic lesion progression in hypercholesterolemic apolipoprotein E–deficient (apoE −/− ) mice and LDLR receptor–deficient (LDLr −/− ) mice. The absence of ABCA1 led to reduced plasma cholesterol levels in both the apoE −/− and LDLr −/− mice, along with severe skin xanthomatosis characterized by marked foamy macrophages and cholesterol ester accumulation. However, the complete absence of ABCA1 did not affect the development, progression, or composition of atherosclerotic lesions in either the LDLr −/− or the apoE −/− mice fed a chow or atherogenic diet. In contrast, bone marrow transplantation studies demonstrated that the selective inactivation of ABCA1 in macrophages markedly increased atherosclerosis and foam cell accumulation in apoE −/− . Taken together, these findings demonstrate that the complete absence of ABCA1 has a major impact on plasma lipoprotein homeostasis, and the proposed antiatherogenic effect resulting from ABCA1 deficiency is compensated by a less atherogenic profile. ABCA1 deficiency in macrophages, however, demonstrates the antiatherogenic properties of ABCA1 independent of plasma lipids and HDL levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cholesterol efflux from cells to apolipoprotein A-I (apoA-I) acceptors via the ATP-binding cassette transporters ABCA1 and ABCG1 is thought to be central in the antiatherogenic mechanism.”
From MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice (2012) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in mice in which the Abca1 locus is either deleted or overexpressed generally have supported the hypothesis that ABCA1 significantly prevents atherosclerosis by maintaining circulating HDL-C levels and cellular cholesterol efflux.10–13”
From MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice (2012) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 7,009
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
The Human ATP-Binding Cassette (ABC) Transporter SuperfamilyPreprint
Dean, M. C., Rzhetsky, A., & Allikmets, R. L. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,820
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics · doi:10.1038/11921 · Cited by 1,433
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J. A., Medina, J. C., Li, L., Lustig, K. D., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,317
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
Research works printed but not linked: 9
Cited by
Sorted by citations
Apoptotic cell clearance: basic biology and therapeutic potential
Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3607 · Cited by 1,223
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,104
Liver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978
Zheng, L., Nukuna, B. N., Brennan, M., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21109 · Cited by 735
The macrophage foam cell as a target for therapeutic intervention
Li, A. C., & Glass, C. K. (2002) · Nature Medicine · doi:10.1038/nm1102-1235 · Cited by 700
Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690
Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
Yvan‐Charvet, L., Wang, N., & Tall, A. R. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179283 · Cited by 683
Liver X Receptor Signaling Pathways in Cardiovascular Disease
Tontonoz, P., & Mangelsdorf, D. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0061 · Cited by 639
HDL Cholesterol and Protective Factors in Atherosclerosis
Assmann, G., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000131512.50667.46 · Cited by 637
HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis
Tall, A. R., Yvan-Charvet, L., Terasaka, N., Pagler, T., & Wang, N. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.001 · Cited by 540
Yvan-Charvet, L., Ranalletta, M., Wang, N., Han, S., Terasaka, N., Li, R., Welch, C., & Tall, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33372 · Cited by 536
Macrophage Reverse Cholesterol Transport
Cuchel, M., & Rader, D. J. (2006) · Circulation · doi:10.1161/circulationaha.104.475715 · Cited by 536
Oram, J. F., & Heinecke, J. W. (2005) · Physiological Reviews · doi:10.1152/physrev.00005.2005 · Cited by 531
Importance of Different Pathways of Cellular Cholesterol Efflux
Yancey, P. G., Bortnick, A. E., Kellner-Weibel, G., de la Llera-Moya, M., Phillips, M. C., & Rothblat, G. H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000057572.97137.dd · Cited by 516
Atherosclerosis in the Apolipoprotein E–Deficient Mouse
Meir, K. S., & Leitersdorf, E. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000128849.12617.f4 · Cited by 498
HDL as a target in the treatment of atherosclerotic cardiovascular disease
Linsel‐Nitschke, P., & Tall, A. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1658 · Cited by 489
Frikke-Schmidt, R. (2008) · JAMA · doi:10.1001/jama.299.21.2524 · Cited by 464
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 469
Timmins, J. M., Lee, J.-Y., Boudyguina, E., Kluckman, K. D., Brunham, L. R., Mulya, A., Gebre, A. K., Coutinho, J. M., Colvin, P. L., Smith, T. L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23915 · Cited by 447
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
Tangirala, R. K., Bischoff, E. D., Joseph, S. B., Wagner, B. L., Walczak, R., Laffitte, B. A., Daige, C. L., Thomas, D., Heyman, R. A., Mangelsdorf, D. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182199799 · Cited by 444
Tall, A. R. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01898.x · Cited by 436
ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease
Oram, J. F., & Vaughan, A. M. (2006) · Circulation Research · doi:10.1161/01.res.0000250171.54048.5c · Cited by 411
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL
Zannis, V. I., Chroni, A., & Krieger, M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0030-4 · Cited by 404
The liver X receptor gene team: Potential new players in atherosclerosis
Repa, J. J., & Mangelsdorf, D. J. (2002) · Nature Medicine · doi:10.1038/nm1102-1243 · Cited by 389
Zhu, X., Lee, J., Timmins, J. M., Brown, J. M., Boudyguina, E. Y., Mulya, A., Gebre, A. K., Willingham, M. C., Hiltbold, E. M., Mishra, N., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801408200 · Cited by 356
Atheroprotective Effects of High-Density Lipoproteins
Assmann, G., & Nofer, J. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152409 · Cited by 345
Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from Macrophages
Mujawar, Z., Rose, H. M., Morrow, M. P., Pushkarsky, T., Dubrovsky, L., Mukhamedova, N., Fu, Y., Dart, A. M., Orenstein, J. M., Bobryshev, Y. V., et al. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040365 · Cited by 335
Reverse cholesterol transport and cholesterol efflux in atherosclerosis
Ohashi, R., Mu, H. H., Wang, X., Yao, Q., & Chen, C. (2005) · QJM · doi:10.1093/qjmed/hci136 · Cited by 336
Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation
Castrillo, A., & Tontonoz, P. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.134432 · Cited by 260
The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor
Tang, C., Liu, Y., Kessler, P. S., Vaughan, A. M., & Oram, J. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047472 · Cited by 284
Vaughan, A. M., & Oram, J. F. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600218-jlr200 · Cited by 291
Wang, N., & Tall, A. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000075912.83860.26 · Cited by 261
ATP-Binding Cassette Transporters, Atherosclerosis, and Inflammation
Westerterp, M., Bochem, A. E., Yvan‐Charvet, L., Murphy, A. J., Wang, N., & Tall, A. R. (2014) · Circulation Research · doi:10.1161/circresaha.114.300738 · Cited by 261
Increased ABCA1 activity protects against atherosclerosis
Singaraja, R. R., Fievet, C., Castro, G., James, E. R., Hennuyer, N., Clee, S. M., Bissada, N., Choy, J. C., Fruchart, J.-C., McManus, B. M., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15748 · Cited by 250
Singaraja, R. R., Brunham, L. R., Visscher, H., Kastelein, J. J. P., & Hayden, M. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000078520.89539.77 · Cited by 248
High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions
Barter, P. J., Kastelein, J. J. P., Nunn, A. V. W., & Hobbs, R. F. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00006-6 · Cited by 242
Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1
Cavelier, C., Lorenzi, I., Rohrer, L., & von Eckardstein, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.04.012 · Cited by 237
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
Vergeer, M., Holleboom, A. G., Kastelein, J. J. P., & Kuivenhoven, J. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r001610 · Cited by 222
Covey, S. D., Krieger, M., Wang, W., Penman, M., & Trigatti, B. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000083343.19940.a0 · Cited by 221
MicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice
Horie, T., Baba, O., Kuwabara, Y., Chujo, Y., Watanabe, S., Kinoshita, M., Horiguchi, M., Nakamura, T., Chonabayashi, K., Hishizawa, M., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003376 · Cited by 220
Besler, C., Lüscher, T. F., & Landmesser, U. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200224 · Cited by 226
Regulation and mechanisms of macrophage cholesterol efflux
Tall, A. R., Costet, P., & Wang, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16391 · Cited by 235
Out, R., Hoekstra, M., Hildebrand, R. B., Kruit, J. K., Meurs, I., Li, Z., Kuipers, F., van Berkel, T. J. C., & Eck, M. V. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000237629.29842.4c · Cited by 204
ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions
Vaughan, A. M., & Oram, J. F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300078-jlr200 · Cited by 203
Out, R., Hoekstra, M., Habets, K. L. L., Meurs, I., de Waard, V., Hildebrand, R. B., Wang, Y., Chimini, G., Kuiper, J., van Berkel, T. J. C., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.156935 · Cited by 199
Medina, C. B., & Ravichandran, K. S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.13 · Cited by 199
The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse
Chisholm, J. W., Hong, J., Mills, S. A., & Lawn, R. M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300135-jlr200 · Cited by 198
ABC transporters, atherosclerosis and inflammation
Fitzgerald, M. L., Mujawar, Z., & Tamehiro, N. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.011 · Cited by 196
Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I
Martinez, L. O., Agerholm-Larsen, B., Wang, N., Chen, W., & Tall, A. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307161200 · Cited by 186
ABC A-subfamily transporters: Structure, function and disease
Kaminski, W. E., Piehler, A. P., & Wenzel, J. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.01.011 · Cited by 183
Eck, M. V., Pennings, M., Hoekstra, M., Out, R., & van Berkel, T. J. C. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000169351.28019.04 · Cited by 181
Shao, B., Pennathur, S., & Heinecke, J. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337345 · Cited by 170
Eck, M. V., Singaraja, R. R., Ye, D., Hildebrand, R. B., James, E. R., Hayden, M. R., & van Berkel, T. J. C. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000208364.22732.16 · Cited by 170
Baldán, Á., Pei, L., Lee, R. G., Tarr, P. T., Tangirala, R. K., Weinstein, M. M., Frank, J. S., Li, A. C., Tontonoz, P., & Edwards, P. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000240051.22944.dc · Cited by 164
Lu, H. S., & Daugherty, A. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305380 · Cited by 171
Emerging roles of the intestine in control of cholesterol metabolism
Kruit, J. K. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i40.6429 · Cited by 165
HDL: The Metabolism, Function, and Therapeutic Importance
Wang, M., & Briggs, M. R. (2003) · Chemical Reviews · doi:10.1021/cr020466v · Cited by 159
Yin, K., Liao, D., & Tang, C. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00004 · Cited by 158
ABCA1 and nascent HDL biogenesis
Wang, S., & Smith, J. D. (2014) · BioFactors · doi:10.1002/biof.1187 · Cited by 161
Lund, E. G., Peterson, L. B., Adams, A. D., Lam, M.-H. N., Burton, C. A., Chin, J., Guo, Q., Huang, S., Latham, M., Lopez, J. C., et al. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.004 · Cited by 148
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology
Rosenson, R. S., Brewer, H. B., Barter, P. J., Björkegren, J., Chapman, M. J., Gaudet, D., Kim, D. S., Niesor, E. J., Rye, K., Sacks, F. M., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.115 · Cited by 149
Aiello, R. J., Brees, D., & Francone, O. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054661.21499.fb · Cited by 146
Self-citationChoudhury, R. P., Lee, J., & Greaves, D. R. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0195 · Cited by 146
Interleukin‐10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice
Han, X., Kitamoto, S., Wang, H., & Boisvert, W. A. (2010) · The FASEB Journal · doi:10.1096/fj.09-148155 · Cited by 145
Brunham, L. R., Singaraja, R. R., & Hayden, M. R. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111214 · Cited by 148
ABCA1-mediated Cholesterol Efflux Is Defective in Free Cholesterol-loaded Macrophages
Feng, B., & Tabas, I. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207532200 · Cited by 143
Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− Mice
Wilhelm, A. J., Zabalawi, M., Owen, J. S., Shah, D., Grayson, J. M., Major, A. S., Bhat, S., Gibbs, D. P., Thomas, M. J., & Sorci‐Thomas, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134130 · Cited by 145
Liver X receptors as regulators of macrophage inflammatory and metabolic pathways
A-González, N., & Castrillo, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.015 · Cited by 139
Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor
Quinet, E. M., Savio, D. A., Halpern, A. R., Chen, L., Miller, C. P., & Nambi, P. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400257-jlr200 · Cited by 144
OSBP-related Protein 8 (ORP8) Suppresses ABCA1 Expression and Cholesterol Efflux from Macrophages
Yan, D., Mäyränpää, M. I., Wong, J., Perttilä, J., Lehto, M. J., Jauhiainen, M., Kovanen, P. T., Ehnholm, C., Brown, A. J., & Olkkonen, V. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705313200 · Cited by 138
Liver X receptors at the intersection of lipid metabolism and atherogenesis
Lee, S. D., & Tontonoz, P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.042 · Cited by 135
Sun, Y., Hao, M., Luo, Y., Liang, C.-P., Silver, D. L., Cheng, C., Maxfield, F. R., & Tall, A. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208687200 · Cited by 134
Genetic Variation in ABCA1 Predicts Ischemic Heart Disease in the General Population
Frikke‐Schmidt, R., Nordestgaard, B. G., Jensen, G. B., Steffensen, R., & Tybjærg‐Hansen, A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.153858 · Cited by 134
Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages
Adorni, M. P., Cipollari, E., Favari, E., Zanotti, I., Zimetti, F., Corsini, A., Ricci, C., Bernini, F., & Ferri, N. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.019 · Cited by 130
Zhang, J. R., Coleman, T., Langmade, S. J., Scherrer, D. E., Lane, L. M., Lanier, M. H., Chu, F., Sands, M. S., Schaffer, J. E., Semenkovich, C. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32561 · Cited by 127
Pennings, M., Meurs, I., Ye, D., Out, R., Hoekstra, M., van Berkel, T. J. C., & Eck, M. V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.022 · Cited by 126
Mulligan, J. D., Flowers, M. T., Oler, A. T., BITGOOD, J. J., Wellington, C. L., Hayden, M. R., & Attie, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212377200 · Cited by 125
Interferon-γ and atherosclerosis: Pro- or anti-atherogenic?
Harvey, E. J., & Ramji, D. P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.019 · Cited by 126
Apolipoprotein A-I and Its Role in Lymphocyte Cholesterol Homeostasis and Autoimmunity
Wilhelm, A. J., Zabalawi, M., Grayson, J. M., Weant, A. E., Major, A. S., Owen, J., Bharadwaj, M. S., Walzem, R. L., Chan, L., Oka, K., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183442 · Cited by 124
Pulmonary abnormalities due to ABCA1 deficiency in mice
Bates, S. R., Tao, J., Collins, H. L., Francone, O. L., & Rothblat, G. H. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00234.2005 · Cited by 123
Self-citationCoffee Consumption Enhances High-Density Lipoprotein-Mediated Cholesterol Efflux in Macrophages
Uto‐Kondo, H., Ayaori, M., Ogura, M., Nakaya, K., Ito, M., Suzuki, A., Takiguchi, S., Yakushiji, E., Terao, Y., Ozasa, H., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.206615 · Cited by 119
High-density lipoproteins and atherosclerosis
Rader, D. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02635-8 · Cited by 116
The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes
Tang, C., & Oram, J. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.011 · Cited by 115
High Density Lipoprotein Biogenesis, Cholesterol Efflux, and Immune Cell Function
Sorci‐Thomas, M. G., & Thomas, M. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300135 · Cited by 116
Study of ABCA1 function in transgenic mice.
Joyce, C. W., Freeman, L., Brewer, H., & Santamarina-Fojo, S. (2003) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000055194.85073.ff · Cited by 118
Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1
Fond, A. M., Lee, C. S., Schulman, I. G., Kiss, R. S., & Ravichandran, K. S. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80300 · Cited by 114
Tolani, S., Pagler, T. A., Murphy, A. J., Bochem, A. E., Abramowicz, S., Welch, C. L., Nagareddy, P. R., Holleran, S., Hovingh, G. K., Kuivenhoven, J. A., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.031 · Cited by 119
HDL Biogenesis, Remodeling, and Catabolism
Zannis, V. I., Fotakis, P., Κούκος, Γ., Kardassis, D., Ehnholm, C., Jauhiainen, M., & Chroni, A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_2 · Cited by 123
Intramural Plasminogen Activator Inhibitor Type-1 and Coronary Atherosclerosis
Sobel, B. E., Taatjes, D. J., & Schneider, D. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000091250.53231.4d · Cited by 112
Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease
Srivastava, R. A. K. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3165-z · Cited by 113
Selva, D. M., Hirsch‐Reinshagen, V., Burgess, B. L., Zhou, S., Chan, J. Y., McIsaac, S. A., Hayden, M. R., Hammond, G. L., Vogl, A. W., & Wellington, C. L. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400007-jlr200 · Cited by 109
Guo, Y., Yuan, W., Yu, B., Kuai, R., Hu, W., Morin, E. E., Garcia-Barrio, M. T., Zhang, J., Moon, J. J., Schwendeman, A. A., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.021 · Cited by 107
Xian, X., Ding, Y., Dieckmann, M., Zhou, L., Plattner, F., Liu, M., Parks, J. S., Hammer, R. E., Boucher, P., Tsai, S. X., et al. (2017) · eLife · doi:10.7554/elife.29292 · Cited by 102
Tissue-Specific Roles of ABCA1 Influence Susceptibility to Atherosclerosis
Brunham, L. R., Singaraja, R. R., Duong, M., Timmins, J. M., Fievet, C., Bissada, N., Kang, M. H., Samra, A., Fruchart, J.-C., McManus, B., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182303 · Cited by 102
He, H., Yuan, Q., Bie, J., Wallace, R. L., Yannie, P. J., Wang, J., Lancina, M. G., Zolotarskaya, O. Y., Korzun, W. J., Yang, H., et al. (2017) · Translational research · doi:10.1016/j.trsl.2017.10.008 · Cited by 103
Genetic Basis of Atherosclerosis: Insights From Mice and Humans
Stylianou, I. M., Bauer, R. C., Reilly, M. P., & Rader, D. J. (2012) · Circulation Research · doi:10.1161/circresaha.110.230854 · Cited by 99
LXRs: new therapeutic targets in atherosclerosis?
Joseph, S. B. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00009-2 · Cited by 102
Albrecht, C., McVey, J. H., Elliott, J. I., Sardini, A., Kasza, I., Mumford, A. D., Naoumova, R. P., Tuddenham, E. G. D., Szabó, K., & Higgins, C. F. (2005) · Blood · doi:10.1182/blood-2004-05-2056 · Cited by 97
Francone, O. L., Royer, L. J., Boucher, G., Haghpassand, M., Freeman, A., Brees, D., & Aiello, R. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166522.69552.99 · Cited by 97
Self-citationSoumian, S., Albrecht, C., Davies, A. H., & Gibbs, R. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm593ra · Cited by 100
Metadata
- Authors
- Aiello, R. J., Brees, D., Bourassa, P.-A., Royer, L., Lindsey, S., Coskran, T., Haghpassand, M., & Francone, O. L.
- Affiliations
- Pfizer (United States) (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2002-04
- Volume
- 22
- Issue
- 4
- Pages
- 630-637
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2128738849
- Cited by
- 390
- References
- 38
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 10 · 2021: 11 · 2020: 8 · 2019: 6 · 2018: 9 · 2017: 14 · 2016: 11 · 2015: 19 · 2014: 22 · 2013: 17 · 2012: 20
- FWCI
- 30.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- ABCA1, atherosclerosis, macrophages, hyperlipidemia, Tangier disease, HDL deficiency, ApoE-deficient mice, LDL receptor-deficient mice, foam cells, xanthomatosis, cholesterol efflux, bone marrow transplantation, atherogenic diet
- MeSH terms
- Animals, Apolipoproteins E, Arteriosclerosis, Cholesterol, Crosses, Genetic, Female, Hyperlipidemias, Lipids, Lipoproteins, Macrophages, Male, Mice, Inbred C57BL, Mice, Inbred DBA, Receptors, LDL, Xanthomatosis, Bone Marrow Transplantation, ATP-Binding Cassette Transporters, Mice, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review